DL-threo-Droxidopa-d3 Hydrochloride Salt Hydrate

CAS: 3916-18-5

Ref. TR-D689954

Informação sobre produto

• Nome: DL-threo-Droxidopa-d3 Hydrochloride Salt Hydrate
• Sinónimos: (2R,3R)-2-ammonio-3-(3,4-dihydroxyphenyl)-3-hydroxypropanoate, (2Rs,3Rs)-2-Amino-3-(3,4-Dihydroxy-Phenyl)-3-Hydroxy-Propionic Acid, (betaR)-beta,3-dihydroxy-L-tyrosine, <span class="text-smallcaps">D</span>-Tyrosine, β,3-dihydroxy-, (βS)-rel-, <span class="text-smallcaps">DL</span>-Tyrosine, β,3-dihydroxy-, threo-, <span class="text-smallcaps">DL</span>-threo-3,4-Dihydroxyphenylserine, <span class="text-smallcaps">DL</span>-threo-DOPS, <span class="text-smallcaps">DL</span>-threo-Dihydroxyphenylserine, D,L-dops F&D version of D-2384, DL-threo-3,4-Dihydroxyphenylserine, H-DL-.beta.-(3,4-Dihydroxyphenyl)-DL-Ser-OH, Serine, 3-(3,4-dihydroxyphenyl)-, <span class="text-smallcaps">DL</span>-threo-, rel-(βS)-β,3-Dihydroxy-<span class="text-smallcaps">D</span>-tyrosine, threo-2-Amino-3-(3,4-dihydroxyphenyl)-3-hydroxypropionic acid

Descrição

Applications DL-threo-Droxidopa-d3 Hydrochloride Salt Hydrate is an isotope labeled compound of DL-threo-Droxidopa (D689950), a synthetic amino acid precursor of Norepinephrine. An Antiparkinson.
References Bartholini, J., et al.: J. Pharmacol. Exp. Ther ., 193, 523 (1975), Kato, T., et al.: Biochem. Pharmacol., 36, 3051 (1987), Kawabata, A., et al.: Br J. Pharmacol., 111, 503 (1994)

• Marca: TRC

Propriedades químicas

• Peso molecular: 216.2136461802
• Fórmula: C₉H₈D₃NO₅•HCl•x(H₂O)
• Cor/forma: Neat
• InChI: InChI=1S/C9H11NO5.ClH.H2O/c10-7(9(14)15)8(13)4-1-2-5(11)6(12)3-4;;/h1-3,7-8,11-13H,10H2,(H,14,15);1H;1H2/t7-,8+;;/m0../s1/i1D,2D,3D
• Chave InChI: InChIKey=GIOBDKSKSVSIOR-OATNUVPVSA-N
• SMILES: Cl.O.[2H]c1c([2H])c([C@@H](O)[C@H](N)C(=O)O)c([2H])c(O)c1O